113 related articles for article (PubMed ID: 21950200)
1. Molecular characterisation of the quinolone resistance-determining region (QRDR) of the parC gene locus in viridans-group streptococci.
Murayama M; Maeda Y; Goldsmith CE; Coulter WA; Masons C; Millar BC; Matsuda M; Moore JE
Br J Biomed Sci; 2011; 68(3):109-11. PubMed ID: 21950200
[TBL] [Abstract][Full Text] [Related]
2. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterisation of the quinolone resistance-determining regions (QRDR) including gyrA, gyrB, parC and parE genes in Streptococcus pneumoniae.
Kakinuma Y; Maeda Y; Mason C; Goldsmith CE; Coulter WA; Matsuda M; Dooley JS; Lowery CJ; Moore JE
Br J Biomed Sci; 2012; 69(3):123-5. PubMed ID: 23057160
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.
Grohs P; Houssaye S; Aubert A; Gutmann L; Varon E
Antimicrob Agents Chemother; 2003 Nov; 47(11):3542-7. PubMed ID: 14576115
[TBL] [Abstract][Full Text] [Related]
5. Comparison of minimum inhibitory concentration by broth microdilution testing versus standard disc diffusion testing in the detection of penicillin, erythromycin and ciprofloxacin resistance in viridans group streptococci.
Maeda Y; Goldsmith CE; Coulter WA; Mason C; Dooley JSG; Lowery CJ; Millar BC; Moore JE
J Med Microbiol; 2011 Dec; 60(Pt 12):1782-1786. PubMed ID: 21852527
[TBL] [Abstract][Full Text] [Related]
6. Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae.
Broskey J; Coleman K; Gwynn MN; McCloskey L; Traini C; Voelker L; Warren R
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():95-9. PubMed ID: 10824039
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae.
Ip M; Chau SS; Chi F; Tang J; Chan PK
Antimicrob Agents Chemother; 2007 Aug; 51(8):2690-700. PubMed ID: 17548487
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis.
Maeda Y; Murayama M; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Matsuda M; Rendall JC; Elborn JS; Moore JE
J Antimicrob Chemother; 2011 Mar; 66(3):476-86. PubMed ID: 21193474
[TBL] [Abstract][Full Text] [Related]
9. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
Balsalobre L; de la Campa AG
Antimicrob Agents Chemother; 2008 Mar; 52(3):822-30. PubMed ID: 18160515
[TBL] [Abstract][Full Text] [Related]
10. Resistance of different Chlamydia-like organisms to quinolones and mutations in the quinoline resistance-determining region of the DNA gyrase A- and topoisomerase-encoding genes.
Casson N; Greub G
Int J Antimicrob Agents; 2006 Jun; 27(6):541-4. PubMed ID: 16697560
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy.
Montanari MP; Tili E; Cochetti I; Mingoia M; Manzin A; Varaldo PE
Microb Drug Resist; 2004; 10(3):209-17. PubMed ID: 15383164
[TBL] [Abstract][Full Text] [Related]
12. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
[TBL] [Abstract][Full Text] [Related]
13. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
14. Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.
Balsalobre L; Ferrándiz MJ; Liñares J; Tubau F; de la Campa AG
Antimicrob Agents Chemother; 2003 Jul; 47(7):2072-81. PubMed ID: 12821449
[TBL] [Abstract][Full Text] [Related]
15. Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).
Davies TA; Yee YC; Goldschmidt R; Bush K; Sahm DF; Evangelista A
J Antimicrob Chemother; 2006 Mar; 57(3):437-42. PubMed ID: 16431861
[TBL] [Abstract][Full Text] [Related]
16. Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis.
Prabhu RM; Piper KE; Litzow MR; Steckelberg JM; Patel R
Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):832-8. PubMed ID: 16331335
[TBL] [Abstract][Full Text] [Related]
17. [Fluoroquinolone resistance determining region mutation in Streptococcus pneumonia isolates].
Zhang FF; Zhao CJ; Wang H
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):940-4. PubMed ID: 24503427
[TBL] [Abstract][Full Text] [Related]
18. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Rice CL; Doern GV
Clin Infect Dis; 2005 Jan; 40(2):225-35. PubMed ID: 15655739
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA
J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174
[TBL] [Abstract][Full Text] [Related]
20. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population.
Rozkiewicz D; Daniluk T; Sciepuk M; Zaremba ML; Cylwik-Rokicka D; Luczaj-Cepowicz E; Milewska R; Marczuk-Kolada G; Stokowska W
Adv Med Sci; 2006; 51 Suppl 1():191-5. PubMed ID: 17460837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
